Full Text View
Tabular View
No Study Results Posted
Related Studies
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), February 2009
First Received: November 14, 2001   Last Updated: September 24, 2009   History of Changes
Sponsor: National Cancer Institute (NCI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00026884
  Purpose

Selected patients suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI. Blood samples may be collected at the time of the initial visit and at periodic intervals during the course of the disease. These samples will be stored in the tissue bank of the Urologic Oncology Branch. Aliquots of malignant and normal tissue will be collected at the time of surgery and stored in the tissue bank, Urologic Oncology Branch, NCI. These materials will be used in the research efforts of the Urologic Oncology Branch, NCI....


Condition
Neoplasm

Study Type: Observational
Official Title: Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 2000
Study Start Date: July 1997
Estimated Primary Completion Date: May 2002 (Final data collection date for primary outcome measure)
Detailed Description:

Selected patients suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI and at the National Naval Medical Center. Blood samples may be collected at the time of the initial visit and at periodic intervals during the course of the disease. These samples will be stored in the tissue bank of the Urologic Oncology Branch. Aliquots of malignant and normal tissue will be collected at the time of surgery and stored in the tissue bank, Urologic Oncology Branch, NCI. These materials will be used in the research efforts of the Urologic Oncology Branch, NCI. Samples will also be collected on the NNMC-IRB approved protocol, "Collection of Serum and Tissue Samples from patients with biopsy proved or suspected malignant disease", NNMC B99-062, from the National Navy Medical Center.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Patients suspected of having, or with biopsy proof of malignant disease are eligible.

Patients must be able to provide informed consent.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00026884

Contacts
Contact: NCI Referral Office 1-888-NCI-1937 ncicssc@mail.nih.gov
Contact: W. Marston Linehan, M.D. (301) 496-6353 linehanm@mail.nih.gov

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

Additional Information:
Publications:
Study ID Numbers: 970147, 97-C-0147
Study First Received: November 14, 2001
Last Updated: September 24, 2009
ClinicalTrials.gov Identifier: NCT00026884     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Tissue Procurement

Additional relevant MeSH terms:
Neoplasms

ClinicalTrials.gov processed this record on November 27, 2009